Yamaguchi, Japan

Masahiro Koga


Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Hino, JA (1978)
  • Iwakuni, JP (1979 - 1996)
  • Yamaguchi, JP (1989 - 2004)

Company Filing History:


Years Active: 1978-2004

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Masahiro Koga: A Pioneer in Vitamin D Innovations

Introduction

Masahiro Koga, located in Yamaguchi, Japan, is a distinguished inventor known for his significant contributions to the field of biochemistry, with a focus on vitamin D derivatives. With a total of eight patents to his name, Koga has demonstrated a strong commitment to advancing pharmaceutical innovations.

Latest Patents

Among his notable inventions are his recent patents, which include "Intermediates for vitamin D and processes for the preparation thereof" and ".alpha.-chain-modified isocarbacyclins and process for the production." These patents highlight Koga's expertise in developing novel compounds that could lead to enhanced therapeutic applications.

Career Highlights

Koga currently works at Teijin Limited, a company renowned for its dedication to research and development in various sectors, including pharmaceuticals. His role at the company has positioned him as a leading figure in the exploration of vitamin D-related inventions, making impactful strides in the industry.

Collaborations

Throughout his career, Koga has collaborated with esteemed colleagues such as Keizo Shimada and Toshiaki Harada. These partnerships have fostered a collaborative environment that has supported the innovation process and the development of groundbreaking inventions in their field.

Conclusion

Masahiro Koga's innovative work and dedication to research exemplify the spirit of invention. His contributions not only enrich the scientific community but also pave the way for advancements in medical science and the understanding of vitamin D. With a promising career ahead, Koga's future inventions are highly anticipated in the world of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…